scispace - formally typeset
L

Livia Vastag

Researcher at Princeton University

Publications -  7
Citations -  1146

Livia Vastag is an academic researcher from Princeton University. The author has contributed to research in topics: Flux (metabolism) & Human cytomegalovirus. The author has an hindex of 7, co-authored 7 publications receiving 958 citations. Previous affiliations of Livia Vastag include Castleton State College.

Papers
More filters
Journal ArticleDOI

Metabolomic analysis and visualization engine for LC-MS data.

TL;DR: A software package designed for efficient interactive analysis of LC-MS data, including in the presence of isotope labeling, that contains tools for all aspects of the data analysis process, from feature extraction to pathway-based graphical data display.
Journal ArticleDOI

Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism.

TL;DR: The results confirm that this is a robust target for HSV-1, and therapeutic interventions at other points in metabolism might prove more effective for treatment of HCMV.
Journal ArticleDOI

Human kinome profiling identifies a requirement for AMP-activated protein kinase during human cytomegalovirus infection

TL;DR: It is proposed that HCMV requires AMPK or related activity for viral replication and reprogramming of cellular metabolism, and a comprehensive RNAi screen predicts that 106 cellular kinases influence growth of the virus.
Journal ArticleDOI

Metabolomics in Drug Target Discovery

TL;DR: Techniques for finding new drug targets using metabolomics and isotope tracers are presented and examples where metabolomics has contributed to identification of anticancer drug targets are discussed.
Journal ArticleDOI

Herpes Simplex Virus 1 Infection Activates Poly(ADP-Ribose) Polymerase and Triggers the Degradation of Poly(ADP-Ribose) Glycohydrolase

TL;DR: This work demonstrates that HSV-1 infection results in changes to NAD+ metabolism by PARP-1/2 and PARG, and as PAR chain accumulation can induce caspase-independent apoptosis, it is speculated that the decrease in PARG levels enhances the auto-PARylation-mediated inhibition of PARP, thereby avoiding premature death of the infected cell.